Boston, US. 6 November, 2025
Phesi has won the Innovation Award for AI-enabled Trial Simulation in the 2025 Clinical Trials Arena Excellence Awards announced today. One of the industry’s most prestigious and widely recognised programs, the award recognizes forward-thinking, innovative companies that drive positive change in the industry.
Phesi was honored for its patient-centric clinical data science solutions, powered by its AI-driven Trial Accelerator™ platform which leverages global, contextualized data from more than 300 million patients across 195 countries and 4,000+ indications.
“Phesi is proud to receive the Innovation Award for AI-enabled Trial Simulation. This achievement builds on our success in winning a Frost & Sullivan Innovation Award last year and the approval of innovative medicines on which we have collaborated. It further demonstrates our commitment to providing predictive patient-centric clinical data science solutions that deliver smarter trials and faster cures for unmet medical needs, saving millions of dollars and months for each trial. We are excited to be recognized as being at the forefront of innovation in today’s increasingly complex and challenging global clinical development arena,” commented Dr Gen Li, President & Founder, Phesi.
Read about our success in Clinical Trials Arena here: https://www.clinicaltrialsarena.com/excellence-awards/featured-company/2025-phesi/